1Elevan Bio is dedicated to advancing peptide therapeutics to improve human health and expand patient access to effective treatments. The company delivers FDA-approved and FDA-expanded-access pharmaceutical peptides aimed at treating chronic diseases in adjunctive, first-line, or potentially curative roles. By leveraging the body’s natural pathways, 1Elevan Bio is at the forefront of a shift away from costly, traditional small-molecule drugs with uncertain outcomes—ushering in a new beginning of pharmacological medicine rooted in science, empowerment, and innovation.
Company Details
- Employees
- 4
- Founded
- 2022
- Address
- 12001 Exit 5 Pkwy, Fishers,indiana 46037,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://1elevan.com
- Keywords
- peptides, compounding pharmacy, biopharmaceuticals, telemedicine, patient access, fda-approved.
- HQ
- Fishers, Indiana
1elevan Bio Questions
1Elevan Bio's website is https://1elevan.com
1Elevan Bio's LinkedIn profile is https://www.linkedin.com/company/1elevanbio
1Elevan Bio has
4 employees.
View email and phone details for 4
employees at 1Elevan Bio.
1Elevan Bio's industry is
Pharmaceutical Manufacturing
1Elevan Bio's top competitors are
Macrocyclics,
United Therapeutics Corporation,
State Of Indiana,
Abound Care Rx,
Eurocine Vaccines,
City Of Fishers,
Basecamp Research,
Xturnpoint,
Adventhealth,
Incog Biopharma Services.
1Elevan Bio's categories are Pharmaceutical Manufacturing
1Elevan Bio's founding year is 2022
